These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11158054)

  • 1. Construction of gene therapy vectors targeting thyroid cells: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the cyclic adenosine 3',5'-monophosphate pathway and demonstration of activity in follicular and anaplastic thyroid carcinoma cells.
    Kitazono M; Chuman Y; Aikou T; Fojo T
    J Clin Endocrinol Metab; 2001 Feb; 86(2):834-40. PubMed ID: 11158054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway.
    Kitazono M; Chuman Y; Aikou T; Fojo T
    Int J Cancer; 2002 May; 99(3):453-9. PubMed ID: 11992417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of gene therapy vectors targeting adrenocortical cells: enhancement of activity and specificity with agents modulating the cyclic adenosine 3',5'-monophosphate pathway.
    Chuman Y; Zhan Z; Fojo T
    J Clin Endocrinol Metab; 2000 Jan; 85(1):253-62. PubMed ID: 10634396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer.
    Barzon L; Bonaguro R; Castagliuolo I; Chilosi M; Gnatta E; Parolin C; Boscaro M; Palù G
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5304-11. PubMed ID: 12414907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells.
    Kitazono M; Robey R; Zhan Z; Sarlis NJ; Skarulis MC; Aikou T; Bates S; Fojo T
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3430-5. PubMed ID: 11443220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
    Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
    Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
    Zhang R; Straus FH; DeGroot LJ
    Thyroid; 2001 Feb; 11(2):115-23. PubMed ID: 11288980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
    Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
    Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter.
    Braiden V; Nagayama Y; Iitaka M; Namba H; Niwa M; Yamashita S
    Endocrinology; 1998 Sep; 139(9):3996-9. PubMed ID: 9724055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of transcriptionally targeted suicide gene/prodrug therapy for thyroid carcinoma with the Cre-loxP system.
    Nagayama Y; Nishihara E; Iitaka M; Namba H; Yamashita S; Niwa M
    Cancer Res; 1999 Jul; 59(13):3049-52. PubMed ID: 10397242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.
    Furuya F; Shimura H; Suzuki H; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
    Endocrinology; 2004 Jun; 145(6):2865-75. PubMed ID: 14976143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A histone deacetylase inhibitor enhances killing of undifferentiated thyroid carcinoma cells by p53 gene therapy.
    Imanishi R; Ohtsuru A; Iwamatsu M; Iioka T; Namba H; Seto S; Yano K; Yamashita S
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4821-4. PubMed ID: 12364480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
    Barzon L; Gnatta E; Castagliuolo I; Trevisan M; Moretti F; Pontecorvi A; Boscaro M; Palù G
    Cancer Gene Ther; 2005 Apr; 12(4):381-8. PubMed ID: 15650765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems.
    Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T
    Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma.
    Yamamoto S; Yamano T; Tanaka M; Hoon DS; Takao S; Morishita R; Aikou T; Kaneda Y
    Cancer Gene Ther; 2003 Mar; 10(3):179-86. PubMed ID: 12637938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells.
    Ishiwata N; Inase N; Fujie T; Tamaoka M; Yoshizawa Y
    Anticancer Res; 2003; 23(2B):1405-9. PubMed ID: 12820402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells.
    Xu J; Hershman JM
    Thyroid; 2006 Feb; 16(2):151-60. PubMed ID: 16676400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.